To study the consequences of CD71 blockade on Treg functions, we used an in vitro protocol of Treg expansion, where a significant Treg proportion coexpressed OX40 and CD71 (Figure 1G), similarly to what we observed ex vivo from HCC. Here, TNFRSF4 is linked to hepatocellular carcinoma.